Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results